Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Outgoing Johnson & Johnson (NYSE:JNJ) CEO William Weldon scored a 30% bump in pay for 2012 between a boost to his salary and to his annual bonus. Weldon will get just over $5 million in salary and bonuses this year, most of it coming from a $1.1 million increase in an annual bonus which will be paid 85% in cash and 15% in company common stock, according to regulatory filings.
The new slate of directors for Olympus Corp. (TYO:7733) is already drawing fire from foreign investors in the endoscopy giant, after its entire board resigned en masse over a $1.7 billion accounting scandal that’s slashed its valuation by about 50% since October.
Investment tycoon Warren Buffet may be ready to ditch his stake in Johnson & Johnson (NYSE:JNJ), he said during a CNBC interview. J&J has "obviously has messed up in a lot of ways in the last few years," the chairman & CEO of Berkshire Hathaway (NYSE:BRK.A) said, referring to a slew of company recalls covering a range of products from hip implants to baby lotion.